Swiss National Bank’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-21,600
| Closed | -$595K | – | 2375 |
|
|
2025
Q3 | $595K | Hold |
21,600
| – | – | ﹤0.01% | 2280 |
|
|
2025
Q2 | $659K | Sell |
21,600
-700
| -3% | -$19.9K | ﹤0.01% | 2271 |
|
|
2025
Q1 | $601K | Hold |
22,300
| – | – | ﹤0.01% | 2311 |
|
|
2024
Q4 | $800K | Hold |
22,300
| – | – | ﹤0.01% | 2293 |
|
|
2024
Q3 | $846K | Sell |
22,300
-500
| -2% | -$20.5K | ﹤0.01% | 2287 |
|
|
2024
Q2 | $1.03M | Hold |
22,800
| – | – | ﹤0.01% | 2157 |
|
|
2024
Q1 | $1.11M | Hold |
22,800
| – | – | ﹤0.01% | 2169 |
|
|
2023
Q4 | $1.22M | Sell |
22,800
-2,700
| -11% | -$137K | ﹤0.01% | 2125 |
|
|
2023
Q3 | $1.49M | Buy |
25,500
+300
| +1% | +$18.8K | ﹤0.01% | 2014 |
|
|
2023
Q2 | $1.59M | Buy |
25,200
+300
| +1% | +$19.1K | ﹤0.01% | 2036 |
|
|
2023
Q1 | $1.57M | Sell |
24,900
-2,900
| -10% | -$173K | ﹤0.01% | 1990 |
|
|
2022
Q4 | $1.48M | Buy |
27,800
+500
| +2% | +$27.1K | ﹤0.01% | 2085 |
|
|
2022
Q3 | $1.53M | Sell |
27,300
-300
| -1% | -$19.8K | ﹤0.01% | 2062 |
|
|
2022
Q2 | $2M | Hold |
27,600
| – | – | ﹤0.01% | 1915 |
|
|
2022
Q1 | $2.19M | Buy |
27,600
+1,100
| +4% | +$99.2K | ﹤0.01% | 1982 |
|
|
2021
Q4 | $2.68M | Sell |
26,500
-400
| -1% | -$39.9K | ﹤0.01% | 1863 |
|
|
2021
Q3 | $2.48M | Sell |
26,900
-900
| -3% | -$86.6K | ﹤0.01% | 1906 |
|
|
2021
Q2 | $2.85M | Sell |
27,800
-1,100
| -4% | -$110K | ﹤0.01% | 1863 |
|
|
2021
Q1 | $2.82M | Buy |
28,900
+400
| +1% | +$36.4K | ﹤0.01% | 1805 |
|
|
2020
Q4 | $2.2M | Sell |
28,500
-400
| -1% | -$30.9K | ﹤0.01% | 1849 |
|
|
2020
Q3 | $2.13M | Hold |
28,900
| – | – | ﹤0.01% | 1685 |
|
|
2020
Q2 | $2.12M | Buy |
28,900
+3,400
| +13% | +$267K | ﹤0.01% | 1681 |
|
|
2020
Q1 | $1.47M | Hold |
25,500
| – | – | ﹤0.01% | 1634 |
|
|
2019
Q4 | $2M | Sell |
25,500
-900
| -3% | -$66.3K | ﹤0.01% | 1734 |
|
|
2019
Q3 | $1.8M | Buy |
26,400
+400
| +2% | +$26.9K | ﹤0.01% | 1731 |
|
|
2019
Q2 | $2.06M | Buy |
26,000
+4,200
| +19% | +$333K | ﹤0.01% | 1679 |
|
|
2019
Q1 | $1.83M | Buy |
21,800
+400
| +2% | +$41.8K | ﹤0.01% | 1715 |
|
|
2018
Q4 | $2.52M | Buy |
21,400
+500
| +2% | +$57.8K | ﹤0.01% | 1416 |
|
|
2018
Q3 | $2.52M | Hold |
20,900
| – | – | ﹤0.01% | 1568 |
|
|
2018
Q2 | $2.41M | Buy |
20,900
+1,300
| +7% | +$142K | ﹤0.01% | 1583 |
|
|
2018
Q1 | $1.68M | Hold |
19,600
| – | – | ﹤0.01% | 1755 |
|
|
2017
Q4 | $1.45M | Buy |
19,600
+1,800
| +10% | +$120K | ﹤0.01% | 1854 |
|
|
2017
Q3 | $1.03M | Hold |
17,800
| – | – | ﹤0.01% | 2049 |
|
|
2017
Q2 | $1.14M | Hold |
17,800
| – | – | ﹤0.01% | 1968 |
|
|
2017
Q1 | $1.02M | Hold |
17,800
| – | – | ﹤0.01% | 2013 |
|
|
2016
Q4 | $1.09M | Hold |
17,800
| – | – | ﹤0.01% | 1977 |
|
|
2016
Q3 | $1.23M | Sell |
17,800
-1,600
| -8% | -$106K | ﹤0.01% | 1839 |
|
|
2016
Q2 | $1.08M | Sell |
19,400
-800
| -4% | -$48.2K | ﹤0.01% | 1911 |
|
|
2016
Q1 | $1.19M | Buy |
20,200
+3,600
| +22% | +$212K | ﹤0.01% | 1801 |
|
|
2015
Q4 | $1.06M | Hold |
16,600
| – | – | ﹤0.01% | 1784 |
|
|
2015
Q3 | $1.11M | Buy |
16,600
+2,200
| +15% | +$156K | ﹤0.01% | 1717 |
|
|
2015
Q2 | $984K | Sell |
14,400
-1,200
| -8% | -$76.2K | ﹤0.01% | 1801 |
|
|
2015
Q1 | $867K | Hold |
15,600
| – | – | ﹤0.01% | 1839 |
|
|
2014
Q4 | $800K | Sell |
15,600
-400
| -3% | -$19.6K | ﹤0.01% | 1859 |
|
|
2014
Q3 | $589K | Hold |
16,000
| – | – | ﹤0.01% | 2001 |
|
|
2014
Q2 | $625K | Hold |
16,000
| – | – | ﹤0.01% | 2037 |
|
|
2014
Q1 | $603K | Buy |
16,000
+3,400
| +27% | +$119K | ﹤0.01% | 2026 |
|
|
2013
Q4 | $476K | Hold |
12,600
| – | – | ﹤0.01% | 2024 |
|
|
2013
Q3 | $547K | Sell |
12,600
-1,600
| -11% | -$64.2K | ﹤0.01% | 1885 |
|
|
2013
Q2 | $514K | Buy |
+14,200
| New | +$432K | ﹤0.01% | 1897 |
|
Other funds holding USNA
NCM
Swiss National Bank's USNA Position: Q4 2025 in Review
Swiss National Bank sold out of Usana Health Sciences (USNA) in Q4 2025, closing a stake of 21,600 shares — an estimated $595K sold.
Swiss National Bank first reported a position in USNA in Q2 2013 and held it in 50 quarters. The position peaked at $2.85M in Q2 2021. 121 funds tracked by Wall St. Rank hold USNA as of Q4 2025.
- Swiss National Bank reported no remaining Usana Health Sciences position as of Q4 2025 after selling out during the quarter.
- Swiss National Bank sold 21,600 Usana Health Sciences shares in Q4 2025, an estimated $595K.
- Swiss National Bank first reported a position in Usana Health Sciences in Q2 2013 and held it in 50 quarters.
- Swiss National Bank's Usana Health Sciences position peaked at $2.85M in Q2 2021.
- 121 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2025.
Based on Swiss National Bank's 13F filing for Q4 2025, filed 12 Feb 2026.